The Wireless-Life Sciences Alliance Board of Directors:

0

Robert B. McCray | President & CEO, WLSA

Robert B. McCray is the President & CEO of the Wireless-Life Sciences Alliance, Chairman of Alliance Healthcare Foundation, Special Advisor to TripleTree LLC, Member of Midmark Corporation Board of Directors, Member of Board of Directors of CONNECT and an active advisor to several companies. Rob leverages over 25 years of experience as a business owner, senior operatingexecutive, and legal and transactional advisor to private and public companies.

Rob has served as President, COO and an early investor in Digital On-Demand, Inc., a retail services technology company that operates under the brandname RedDotNet in chains including Barnes & Noble, Circuit City, Best Buy, Blockbuster and Fred Meyer. Previously, he served as Chairman, President and CEO of HealthCap, Inc., a venture capital-backed physician practice management company that returned 90% CAGR to its investors. Rob alsoserved as Managing Director of Caremark Physician Resources, directing its formation during its initial high-growth years prior to its sale to MedPartners, Inc. He also co-founded OnCall Medicine, Inc., a medical house calls company. Prior to his success as a business operator, he was a Managing Partner in hislaw firm and a partner in a predecessor and transactional legal and consulting services to the healthcare industry for over 20 years.

Don Jones | VP, Health & Life Sciences, Qualcomm

Donald Jones serves as vice president of business development for health & life sciences at Qualcomm. He is responsible for Qualcomm’s enablement of wireless technologies in the health and life sciences markets. In 2005, he founded the Wireless-Life Sciences Alliance (WLSA), a 501c(6) trade organization that works with both the wireless and life science industries to enable new business models, new businesses and clinical process improvements in all sectors of the life sciences industry.

Prior to joining Qualcomm, Jones spent 22 years developing and growing healthcare enterprises. He served as chief operating offi cer of MedTrans (now American Medical Response – AMR), the world’s largest emergency medical services provider. Jones was founder and chairman of EMME, Mexico’s largest member-based, subscription health service. He was senior vice president of marketing for HealthCap, a venture capital backed startup, which rapidly grew to become the second largest provider of women’s healthcare in the United States. Jones has extensive experience in mergers and acquisitions, having been involved in more than 130 acquisitions. In 1980, he developed the $2 billion critical care transportation sector, and led AMR’s strategic entry into emergency physician practice management, including the acquisition of EMCARE, the largest US emergency medicine practice. He developed the strategy and worked with AMR CEO and executives to launch American Medical Pathways, winner of a $600 million healthcare call center contract. In 2000, the Journal of Emergency Medical Services (JEMS) named Jones One of the 20 Most Influential People in EMS.

As Founder and Chairman of the WLSA he created the Convergence Summit, a prominent global event, hosted by the CEO of Qualcomm and Johnson & Johnson, and Wireless Health 2010, the first global academic conference on Wireless Health, in conjunction with more than 30 of the world’s top engineeringuniversities. He is on the boards of the Alliance Healthcare Foundation and the American Telemedicine Association. Jones was a founding board member of the West Wireless Health Institute with Eric Topol, M.D. and Gary and Mary West, the world’s first and foremost institute focused on the clinical efficacy and economic efficiencies of wireless technologies in healthcare. In 2010, the San Diego Transcript named Jones one of “San Diego’s Top Influentials.”Jones holds a bachelors’ degree in biology and bio-engineering (University of California, San Diego), a Juris Doctor (University of San Diego), and an MBA (University of California, Irvine.) Jones holds a patent in the use of cell phones in health incentive programs.

Jeffrey K. Belk | VP, Wireless Convergence, WLSA

In addition to his Vice President position with the WLSA, Jeffrey Belk is Managing Director of ICT168 Capital, LLC, focused on developing and guiding global growth opportunities in the ICT (Information and Communication Technology space). Formerly, Belk spent almost 14 years at Qualcomm, where prior to his departure in early 2008, he was Qualcomm’s senior vice president of strategy and market development, focused on examining changes in the wireless ecosystem and formulating approaches to help accelerate mobile broadband adoption and growth.

From 2000 until 2006, Belk was senior vice president, global marketing,leading a team responsible of all facets of the company’s corporate messaging, communications, and marketing worldwide. In 1999-2000, Belk was SVP & GM of Qualcomm Eudora Products, Qualcomm’s award winning email client. In 1997, Belk was named VP, marketing of Qualcomm Consumer Products, and initiated the company’s global branding and communications efforts.  Prior to Qualcomm, Belk spent ten years in the early growth years of the PC industry, primarily with Proxima Corporation. Belk joined the company in 1983, when the company was less than 25 employees, and was with the company through its IPO in the early 90’s in several key distribution, product management, and international roles.

Belk is on the Board of Directors of Peregrine Semiconductors, InterDigital Corporation, as well as the Board of the Wireless Life Sciences Alliance. He has a BA in Economics from University of California, San Diego, and an M.B.A. from the University of California, Irvine. He is known globally as a commentator and writer on wireless, mobile broadband, and technology evolution.

Sharon Henry | Director, American Medical Response

Sharon Henry currently directs wireless initiatives for Emergency Medical Services Corporation (EMSC), the nation’s leading provider of ambulance and outsourced physician services. American Medical Response provides the nation’s largest emergency and non-emergency ambulance service, while EMCARE is the leading provider of outsourced physician services to hospital emergency departments, inpatient physician services, inpatient radiology management programs and anesthesiology services. EMSC also provides air ambulance service and offshore medical services to oil platforms in theGulf. EMSC provides services each year to more than 10 million patients in more than 2,000 communities nationwide. Sharon’s background in market application and implementation allows EMSC to move further into wireless digital medicine.

Sharon has been in the ambulance service business for thirty years, ten of which were in mergers and acquisitions during the roll-up of ambulance companies to large providers in the late 1990s. She co-founded MedicWest Ambulance in Las Vegas, Nevada which grew from a start-up to becoming a large provider in all of Clark County, including the famous Las Vegas Strip.MedicWest was sold to EMSC in 2007, and is now the sole provider of service in the Las Vegas market. Sharon has managed large national performance based ambulance contracts and 911 emergency call centers.

She has a B.S. Degree from Oregon State University and an M.B.A. from the University of California, Irvine.

M. Wainright Fishburn, Jr. | Partner, Cooley Godward Kronish LLP

Wain Fishburn is a founding partner of Cooley LLP’s San Diego office and represents high growth technology and life sciences corporations ranging from start-up to public. Mr. Fishburn is an active community leader and has shaped many industry organizations. He is a founding board member of the Corporate Directors Forum, as well as BIOCOM, where he currently serves as Vice Chair of the BIOCOM Board of Directors. He is a member of the Board of Trustees and the Executive Committee of the Sanford-Burnham Institute for Medical Research. He serves on the Board of Directors for the Critical Path Institute, an independent institute created in part by the FDA, dedicated toimproving the regulatory path for innovative medical therapies. Mr. Fishburn is a founder of two public companies and prior to law school, worked in the corporate environment assisting with the divestiture of a group of 12 operating companies.

He received his J.D. degree from the University of California, Hastings College of the Law, and has served as President of the Hastings Board of Governors.